Drug - International Biopharmaceutical Industry

news

ProQR to lay off 30% of staff following eye drug setback

Dive Brief: ProQR Therapeutics is overhauling its research, cutting staff and trying to find a new way forward for its lead drug after a surprising study failure i...

14 April 2022 news Drug | eye

Continue Reading →

news

Halozyme, doubling down on a licensing strategy, buys a drug delivery biotech for nearly $1B

Dive Brief: Halozyme Therapeutics, a San Diego-based company whose business revolves around a type of drug delivery technology, announced Wednesday plans to expand...

14 April 2022 news delivery | Drug

Continue Reading →

news

FDA clears Gilead to restart some studies of top cancer drug

Dive Brief: The Food and Drug Administration has cleared Gilead to restart some trials testing an experimental cancer drug the company acquired in a roughly $5 bil...

14 April 2022 news cancer | Drug

Continue Reading →

news

Medicare finalizes policy limiting coverage of Biogen Alzheimer’s drug

Medicare will not pay for Biogen's new Alzheimer's medicine unless prospective patients are enrolled in a clinical trial, the U.S. government said Thursday in a decis...

11 April 2022 news Alzheimer | Biogen

Continue Reading →

news

Akebia to lay off 42% of workforce, suspend trials after FDA drug rejection

Dive Brief: Akebia Therapeutics will lay off 42% of its workforce after the Food and Drug Administration last month rejected its most advanced experimental drug, a...

11 April 2022 news Akebia | Drug

Continue Reading →

news

Pfizer buys a private biotech and its RSV drug research

Dive Brief: Pfizer said Thursday it will spend as much as $525 million to buy the privately held biotech ReViral, adding experimental treatments for respiratory sy...

11 April 2022 news Biotech | Drug

Continue Reading →

news

Novartis breast cancer drug approved for ultra-rare condition

Dive Brief: The Food and Drug Administration has approved the first drug to treat an ultra-rare cluster of conditions caused by mutations in a specific gene, grant...

11 April 2022 news breast | cancer

Continue Reading →

news

FDA rejects Akebia drug, dealing another blow to anemia pills

Dive Brief: The Food and Drug Administration rejected an Akebia Therapeutics' anemia pill vadadustat, the company announced Wednesday, over concerns the drug isn't...

1 April 2022 news Akebia | anemia

Continue Reading →

news

FDA advisers narrowly side against an experimental ALS drug, likely lowering its approval chances

By a slim margin, advisers to the Food and Drug Administration have concluded that the agency should hold off approving a closely watched, experimental medicine for A...

1 April 2022 news ALS | Amylyx

Continue Reading →

news

How a long shot ALS drug came before the FDA

The drug's beginnings, according to the two former students there to see them, were quite humble. About a decade ago, Justin Klee and Josh Cohen were undergraduates ...

1 April 2022 news ALS | approval

Continue Reading →